Alpha Teknova (TKNO) Expected to Release Earnings on Wednesday

Alpha Teknova (NASDAQ:TKNO) is expected to be posting its Q3 2026 results after the market closes on Wednesday, November 4th. Analysts expect the company to post earnings of ($0.06) per share and revenue of $11.71 million for the quarter. Investors may review the information on the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Wednesday, November 4, 2026 at 6:00 PM ET.

Alpha Teknova (NASDAQ:TKNO) last posted its quarterly earnings results on Wednesday, August 5th. The company reported ($0.06) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.02. The business had revenue of $12.19 million for the quarter, compared to the consensus estimate of $10.95 million. On average, analysts expect Alpha Teknova to post ($0.28) EPS for the current fiscal year and ($0.23) EPS for the next fiscal year.

Alpha Teknova Trading Up 3.0%

Shares of Alpha Teknova stock traded up $0.21 on Wednesday, reaching $7.32. 26,603 shares of the company were exchanged, compared to its average volume of 249,248. The company has a 50-day moving average of $7.67 and a 200 day moving average of $4.83. The company has a market capitalization of $393.11 million, a price-to-earnings ratio of -23.61 and a beta of 0.85. Alpha Teknova has a one year low of $1.91 and a one year high of $9.48.

Analyst Ratings Changes

Several research analysts have commented on the company. Weiss Ratings downgraded Alpha Teknova from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Tuesday, August 11th. BTIG Research raised Alpha Teknova from a “neutral” rating to a “buy” rating and set a $8.00 price target on the stock in a research note on Tuesday, August 11th. Zacks Research raised shares of Alpha Teknova to a “hold” rating in a research report on Thursday, August 6th. Wall Street Zen raised shares of Alpha Teknova from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th. Finally, Roth Capital started coverage on Alpha Teknova in a research note on Wednesday, August 5th. They issued a “buy” rating and a $7.00 price objective for the company. Four research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $8.75.

About Alpha Teknova

Alpha Teknova, Inc is a life sciences company that develops and manufactures critical reagents and other products used in biomedical research, biopharmaceutical development and advanced therapies. The company provides laboratory and production materials designed to support applications including cell and gene therapy, molecular diagnostics, next-generation sequencing, vaccine development and pharmaceutical manufacturing.

Its offerings include research-use-only and current Good Manufacturing Practice (cGMP) reagents, buffers, media and other custom-formulated solutions.